Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Asset Utilization Ratio (2016 - 2022)

Aptevo Therapeutics' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.09 for Q4 2022.

  • For Q4 2022, Asset Utilization Ratio fell 53.64% year-over-year to 0.09; the TTM value through Dec 2022 reached 0.09, down 53.64%, while the annual FY2022 figure was 0.07, 69.27% down from the prior year.
  • Asset Utilization Ratio for Q4 2022 was 0.09 at Aptevo Therapeutics, down from 0.19 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.85 in Q2 2020 and bottomed at 0.09 in Q4 2022.
  • The 5-year median for Asset Utilization Ratio is 0.22 (2018), against an average of 0.28.
  • The largest annual shift saw Asset Utilization Ratio soared 207.79% in 2020 before it crashed 84.21% in 2021.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.23 in 2018, then skyrocketed by 149.15% to 0.57 in 2019, then crashed by 83.35% to 0.09 in 2020, then surged by 115.16% to 0.2 in 2021, then crashed by 53.64% to 0.09 in 2022.
  • Per Business Quant, the three most recent readings for APVO's Asset Utilization Ratio are 0.09 (Q4 2022), 0.19 (Q3 2022), and 0.24 (Q2 2022).